Clinical Trials Browser

Phase 1/2 × Lymphoma, B-Cell × CTL019 chimeric antigen receptor × Clear all

NCT01626495 2020-03-23

Pedi CART19

Phase 1/2 Completed

73 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell